in sham-operated dogs without cao , neither the angiotensin ii blocker saralasin nor the converting enzyme inhibitor captopril had significant effects on systemic ( svr ) and coronary ( cvr ) vascular resistances .
C0003009
angiotensin ii
C0036193
saralasin